NCT06809088View on ClinicalTrials.gov

Comparison of Safety and Efficacy of Tailored Versus Fixed Dose Albumin for the Management of Patients With Cirrhosis and Sepsis Associated Acute Kidney Injury

NANot yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Liver CirrhosisAcute Kidney Injury

Interventions

BIOLOGICAL

Albumin

OTHER

Standard Medical Treatment

Trial Locations (1)

110070

Institute of liver and Biliary Sciences, New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT06809088 - Comparison of Safety and Efficacy of Tailored Versus Fixed Dose Albumin for the Management of Patients With Cirrhosis and Sepsis Associated Acute Kidney Injury | Biotech Hunter | Biotech Hunter